MAPT and Alzheimer disease: FUTURE DIRECTIONS: Additional work is needed to integrate amyloid and tau PET into diagnostic algorithms and clinical practice guidelines that consider the broader, growing landscape of molecular biomarkers of AD pathophysiology.